BBC vs. IHE
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and IHE (iShares U.S. Pharmaceuticals ETF) are both Health & Biotech Equities funds - BBC tracks the LifeSci Biotechnology Clinical Trials Index while IHE tracks the Dow Jones U.S. Select Pharmaceuticals Index. Both are passively managed. Over the past 10 years, BBC returned 7.60%/yr vs 7.69%/yr for IHE. A 0.64 correlation means they provide meaningful diversification when combined. BBC charges 0.79%/yr vs 0.42%/yr for IHE.
Performance
BBC vs. IHE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 8.17% return, which is significantly higher than IHE's 5.25% return. Both investments have delivered pretty close results over the past 10 years, with BBC having a 7.60% annualized return and IHE not far ahead at 7.69%.
BBC
- 1D
- -4.90%
- 1M
- -4.81%
- YTD
- 8.17%
- 6M
- 20.12%
- 1Y
- 123.11%
- 3Y*
- 19.82%
- 5Y*
- -2.05%
- 10Y*
- 7.60%
IHE
- 1D
- -1.44%
- 1M
- 1.13%
- YTD
- 5.25%
- 6M
- 7.86%
- 1Y
- 38.69%
- 3Y*
- 17.02%
- 5Y*
- 9.73%
- 10Y*
- 7.69%
BBC vs. IHE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.17% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
IHE iShares U.S. Pharmaceuticals ETF | 5.25% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 13.66% | 15.47% | -7.76% | 10.64% |
Correlation
The correlation between BBC and IHE is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.60 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.52 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.53 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.61 |
Correlation (All Time) Calculated using the full available price history since Dec 18, 2014 | 0.64 |
The correlation between BBC and IHE shifts across timeframes, from 0.52 (3 years) to 0.64 (all time), reflecting how their relationship changes across market environments.
BBC vs. IHE - Sectors Allocation Comparison
Sectors
BBC
IHE
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
BBC
IHE
Basic Materials
BBC
-
IHE
-
Communication Services
BBC
-
IHE
-
Consumer Cyclical
BBC
-
IHE
-
Consumer Defensive
BBC
-
IHE
-
Energy
BBC
-
IHE
-
Financial Services
BBC
-
IHE
-
Industrials
BBC
-
IHE
-
Real Estate
BBC
-
IHE
-
Technology
BBC
-
IHE
-
Utilities
BBC
-
IHE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. IHE — Risk / Return Rank
BBC
IHE
BBC vs. IHE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBC | IHE | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.49 | 2.28 | +1.21 |
Sortino ratioReturn per unit of downside risk | 4.11 | 3.33 | +0.79 |
Omega ratioGain probability vs. loss probability | 1.48 | 1.39 | +0.09 |
Calmar ratioReturn relative to maximum drawdown | 8.82 | 4.65 | +4.17 |
Martin ratioReturn relative to average drawdown | 28.55 | 14.05 | +14.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBC | IHE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.49 | 2.28 | +1.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 0.60 | -0.66 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.20 | 0.43 | -0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | 0.50 | -0.39 |
Drawdowns
BBC vs. IHE - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, which is greater than IHE's maximum drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for BBC and IHE.
Loading charts...
Drawdown Indicators
| BBC | IHE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -38.20% | -38.65% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -8.47% | -6.63% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -15.92% | -38.53% |
Max Drawdown (5Y)Largest decline over 5 years | -72.44% | -16.03% | -56.41% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | -29.59% | -47.26% |
Current DrawdownCurrent decline from peak | -30.57% | -3.91% | -26.66% |
Average DrawdownAverage peak-to-trough decline | -37.14% | -7.92% | -29.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.66% | 2.80% | +1.86% |
Volatility
BBC vs. IHE - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 11.21% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 5.43%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBC | IHE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.21% | 5.43% | +5.78% |
Volatility (6M)Calculated over the trailing 6-month period | 26.65% | 12.51% | +14.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.74% | 17.05% | +18.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.31% | 16.23% | +23.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.75% | 18.05% | +19.70% |
BBC vs. IHE - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than IHE's 0.42% expense ratio.
Dividends
BBC vs. IHE - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.57%, less than IHE's 1.67% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.57% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
IHE iShares U.S. Pharmaceuticals ETF | 1.67% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
Frequently Asked Questions
BBC and IHE have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (11.21%) compared to IHE (5.43%). In terms of maximum drawdown, BBC dropped -76.85% vs IHE's -38.20%.
On 10-year performance, IHE leads with 7.69% vs 7.60% for BBC. On fees, IHE is cheaper at 0.42% per year. On volatility, IHE has been the lower-risk option at 5.43%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, IHE has performed better with a 7.69% return vs 7.60%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IHE is cheaper with a 0.42% expense ratio, compared with 0.79% for BBC.
IHE has the higher dividend yield at 1.67%, compared with 1.57% for BBC.
BBC tracks LifeSci Biotechnology Clinical Trials Index, while IHE tracks Dow Jones U.S. Select Pharmaceuticals Index. They also come from different issuers: Virtus Investment Partners and iShares. Their fees differ too: 0.79% for BBC and 0.42% for IHE.
BBC currently has the higher Sharpe Ratio (3.49 vs 2.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBC and IHE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer